Dexcom G7 15 Day
Extended-wear prescription glucose sensor is intended for adults with diabetes.
Keep in mind The manufacturer reports 73.9% of sensors lasting the full 15 days.
Compare up to 10 devices across categories. Keep the purpose and the source beside the numbers.
Lowest recorded store prices take priority over announced or launch prices, within the selected source market. Currencies use the dated EUR reference rates. Deposits and recurring charges are excluded from price order; missing prices stay last. Original price records remain visible.
Extended-wear prescription glucose sensor is intended for adults with diabetes.
Keep in mind The manufacturer reports 73.9% of sensors lasting the full 15 days.
Over-the-counter glucose system announced for adults with type 2 diabetes who do not use insulin.
Keep in mind FDA clearance is not proof of released sales. Lingo and Libre-family specifications are not substituted.
Published specifications and documented constraints. See the full comparison below for prices and sources.
Scroll across the table to compare every model
| Biosensors & healthAdd a model | ![]() | ![]() |
|---|---|---|
| Prices · all markets | Price not verified 0 offer records & sourcesNo verified price in this audit. | Price not verified 0 offer records & sourcesNo verified price in this audit. |
| Designed for | Extended-wear prescription glucose sensor is intended for adults with diabetes. ↗ | Over-the-counter glucose system announced for adults with type 2 diabetes who do not use insulin. ↗ |
| Form factor | Wearable glucose sensor ↗ | Continuous glucose biosensor ↗ |
| Measurement | Continuous interstitial glucose ↗ | Interstitial glucose monitoring ↗ |
| Intended Users | Adults ages 18+ with diabetes ↗ | Adults 18+ with type 2 diabetes, not using insulin ↗ |
| Wear Duration | Up to 15 days ↗ | Not verified |
| Interface | Compatible app or receiver ↗ | CGM system for glucose-pattern review ↗ |
| Purpose Class | Medical CGM ↗ | Not applicable to this category |
| Integrations | Check exact compatible pump and phone list ↗ | Not applicable to this category |
| USRegulatory | Not applicable to this category | FDA OTC iCGM clearance announced June 2024 ↗ |
| Availability | Dexcom current portfolio and G7 page document G7 15 Day as a separate system. | Official 2024 clearance announcement confirmed; no current exact Libre Rio retail launch or price verified. |
| Important context |
|
|
| Editorial pick & release | No editorial ranking recorded | No editorial ranking recorded |
| Evidence | Manufacturer source Checked 2026-10-13 | Manufacturer source Checked 2026-10-13 |
Battery claims use different conditions and are not a controlled benchmark. “Not verified” is an evidence gap, not a missing feature. Prices are dated regional snapshots. Deposits, bundles and historical launch prices are labelled. Brightness measurement methods and battery workloads vary by manufacturer.